CRISPR THERAPEUTICS AG earnings per share and revenue

CRSP/N earnings per share for the last quarter are -32.37 MXN whereas the estimation was -25.48 MXN which accounts for -27.05% surprise. Company revenue for the same period amounts to 17.72 M MXN despite the estimated figure of 128.90 M MXN. Estimated earnings per share for the next quarter are -26.39 MXN, and revenue is expected to reach 126.73 M MXN. Also watch annual changes over time to get a bigger picture of CRSP/N earnings per share and revenue dynamics.